Nuvalent, Inc.

NUVL

⚠ Showing the latest available close (Jul 21, 2026, 107 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

We are a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. We leverage our team's deep expertise in chemistry and structure-based drug design to develop innovative small molecules that are designed with the aim to overcome the limitations of existing therapies for clinically proven kinase targets.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$9.75B

EPS-$6.06

P/E-20.46

P/FCF–

EV/EBITDA-19.29

FCF Yield–

Div. Yield–

Net Debt/FCF–

Nuvalent, Inc. intrinsic value

52-Week Range

$88.49$123.96

Profitability & Returns

TTM as of 2026-03 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue

N/A

Net Income (TTM)

-$450M

▼ -63.1% YoY

Op. Margin

–

ROIC

-32.96%

▼ -3.2pp YoY

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF

N/A

Op. Cash Flow (TTM)

-$313M

▼ -48.7% YoY

Net Debt

-$1.29B

Net Cash Position

Cash & Equiv.

$1.29B

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

Peers

Pharmaceutical Preparations · Pick stocks to compare with NUVL

CompareIntrinsic value

SLNOSoleno Therapeutics Inc

No recent price25

OPKOpko Health Inc.

$1.77+2.91%25

IBIOiBio, Inc.

$0.80-2.44%10

LFVNLifeVantage Corporation

$5.97+3.65%73

PAHCPhibro Animal Health Corporation

$39.43+4.73%57

HOOKHookipa Pharma Inc.

No recent price20

VCNXVaccinex, Inc.

$0.70-1.39%10

PTIXProtagenic Therapeutics, Inc.

$0.65+4.84%20

Held by ETFs

NUVL is in 12 US ETFs. The largest of them, with NUVL's weight in each:

Nuvalent (NUVL) in two numbers

Dividend: None; No dividend in the SEC filings we hold.; Dividends
P/E: -20.46; Negative: a loss over the last twelve months.; Financials

Questions about Nuvalent

Does Nuvalent (NUVL) pay a dividend?

No. Nuvalent (NUVL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 7 May 2026 (period ending 31 Mar 2026), SEC. Price: last close 21 Jul 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in NUVL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NUVL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.